Keywords: Valeant, ISTA Pharma, M&A, Beposone, Ph II, Allergic rhinitis

Valeant pulls out of deal with ISTA, which announces Beposone progress

Article | 31 January 2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has withdrawn its increased offer to acquire US ophthalmic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Valeant Pharmaceuticals

ISTA Pharmaceutical

Go to company listing

Related Drugs

Beposone

Go to drug listing